Jacques Rachelle Suzanne - Insider Non-Derivative Transactions at Akari Therapeutics Plc (AKTX) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Apr 26, 2024, Jacques Rachelle Suzanne's relationship to Akari Therapeutics Plc (AKTX) is Director,Officer (Chief Executive Officer), and currently has 1,018,027,792 shares of Ordinary Shares, par value $0.0001 per share.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other AKTX insiders.
Data Source: SEC.
Jacques Rachelle Suzanne - Insider Non-Derivative Transactions at AKTX
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Apr 27, 2024 | Acquisition -- (Ordinary Shares, par value $0.0001 per share) | 479569892 | 0 | 1018027792 |